Hims & Hers HealthHIMS -5.26%81 Quick Ratio is 1.56 as of Mar. 2026, which is 51% below its 10-year median of 3.19. GuruFocus rates HIMS with a GF Score™ of 81/100 and a GF Value™ of $38.65 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 997 Drug Manufacturers companies, Hims & Hers Health ranks better than 53.46% on this metric.
Hims & Hers Health has a quick ratio of 1.56. It generally indicates good short-term financial strength.
The historical rank and industry rank for Hims & Hers Health's Quick Ratio or its related term are showing as below:
HIMS'
s Quick Ratio Range Over the Past 10 Years
Min: 1.32 Med: 3.19 Max: 17.06
Current: 1.56
During the past 7 years, Hims & Hers Health's highest Quick Ratio was 17.06. The lowest was 1.32. And the median was 3.19.
HIMS's Quick Ratio is ranked better than 53.46% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs HIMS: 1.56
Hims & Hers Health (NYSE:HIMS) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Hims & Hers Health Quick Ratio Related Terms
Hims & Hers Health Quick Ratio Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Hims & Hers Health's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (HIMS) has a Quick Ratio of 1.56 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Hims & Hers Health and its competitors. This is 51% below median its historical median of 3.19. Over the past decade, Hims & Hers Health's Quick Ratio has ranged from 1.32 to 17.06. According to the industry distribution chart, Hims & Hers Health ranks #464 out of 997 companies in the Drug Manufacturers industry, placing it in the top 46.5%.
Is Hims & Hers Health's Quick Ratio too high?
Hims & Hers Health's current Quick Ratio of 1.56 is 51% below median its 10-year median of 3.19. Over the past 10 years, this metric has ranged from a low of 1.32 to a high of 17.06. The Drug Manufacturers industry median Quick Ratio is 1.45. Hims & Hers Health's value of 1.56 is 7.6% above this industry median. Based on the distribution chart, Hims & Hers Health ranks #464 out of 997 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hims & Hers Health has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Quick Ratio compare to LNTH and LQDA?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #464 out of 997 companies for Quick Ratio. This puts Hims & Hers Health in the upper half of its industry. The industry median Quick Ratio is 1.45. Hims & Hers Health's value of 1.56 is 7.6% above this benchmark. Historically, Hims & Hers Health's own Quick Ratio has ranged from 1.32 to 17.06 over the past decade. While the company's 10-year median is 3.19 vs. the industry median of 1.45, Hims & Hers Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hims & Hers Health's current Quick Ratio of 1.56 is 7.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Hims & Hers Health and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current Quick Ratio is 1.56, which is 51% below median its own 10-year median of 3.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is $38.65, compared to a current price of $30.98 — trading 19.8% below its estimated fair value. The current Quick Ratio is 1.56, which is 51% below median its 10-year median of 3.19 and 7.6% above the Drug Manufacturers industry median of 1.45. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Quick Ratio is 1.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of $30.98 is trading 19.8% below its estimated GF Value™ of $38.65.
GuruFocus considers Hims & Hers Health to be Modestly Undervalued.
Key valuation signals for HIMS:
Quick Ratio: 1.56 (51% below median its 10-year median of 3.19)
GF Value™: $38.65 vs. price of $30.98 (19.8% below fair value)
Industry Position: 7.6% above the Drug Manufacturers median (#464 of 997)
No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score
Get the complete analysis for HIMS
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIMS has been successfully added to your 
